Share Price and Basic Stock Data
Last Updated: December 30, 2025, 7:43 pm
| PEG Ratio | 49.53 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Vakrangee Ltd, operating in the IT Consulting and Software industry, reported a stock price of ₹7.73 and a market capitalization of ₹834 Cr. The company has seen fluctuating revenue trends over the past few quarters. Sales for the quarter ending September 2022 stood at ₹234.07 Cr, but significantly dropped to ₹49.15 Cr by December 2022. A slight recovery was observed in subsequent quarters, with sales reaching ₹55.59 Cr in June 2023 and ₹51.54 Cr in September 2023. Despite these fluctuations, the trailing twelve months (TTM) revenue recorded was ₹269 Cr, indicating some recovery from the lows of previous years. Over the fiscal years, from March 2022 to March 2025, sales increased from ₹194 Cr to ₹255 Cr, showcasing an upward trend though revenue levels remain below historical highs, like the ₹4,000 Cr recorded in March 2017. The company’s ability to stabilize and grow its revenue amidst these trends will be crucial for its future performance.
Profitability and Efficiency Metrics
In terms of profitability, Vakrangee reported a net profit of ₹10 Cr, with a net profit margin of 2.50% for the fiscal year ending March 2025. Operating profit margin (OPM) for the same period was 10.52%, reflecting moderate operational efficiency. The company has seen a gradual improvement in its operating profit from ₹18 Cr in March 2022 to ₹24 Cr in March 2025. However, the return on equity (ROE) and return on capital employed (ROCE) stood at 3.65% and 5.86%, respectively, indicating relatively low returns compared to industry standards. The interest coverage ratio (ICR) was robust at 15.39x, suggesting that the company can comfortably meet its interest obligations. The cash conversion cycle (CCC) was recorded at 45 days, which is reasonable but indicates room for improvement in operational efficiency. Overall, while profitability metrics show some potential, they remain below optimal levels, necessitating strategic enhancements.
Balance Sheet Strength and Financial Ratios
Vakrangee’s balance sheet reflects a cautious financial stance, with total borrowings reported at ₹4 Cr against reserves of ₹100 Cr. This low level of debt contributes to a debt-to-equity ratio of 0.00, indicating minimal financial leverage. The current ratio stands at 2.15, showcasing a strong liquidity position, while the quick ratio of 1.90 confirms that the company can meet its short-term obligations without relying on inventory sales. The price-to-book value (P/BV) ratio is relatively high at 5.75x, which may suggest overvaluation compared to sector norms. Additionally, the company’s asset turnover ratio improved to 0.83%, signaling better utilization of assets to generate revenue. However, the book value per share significantly declined from ₹25.93 in March 2022 to ₹1.64 in March 2025, raising concerns about the company’s long-term asset management and valuation. The balance sheet indicates a conservative approach to managing liabilities while maintaining sufficient liquidity.
Shareholding Pattern and Investor Confidence
As of March 2025, Vakrangee’s shareholding pattern reveals a diverse ownership structure, with promoters holding 40.05%, foreign institutional investors (FIIs) at 0.83%, domestic institutional investors (DIIs) at 4.47%, and the public holding a substantial 54.66%. The increasing public shareholding from 43.15% in December 2022 to 54.66% in March 2025 indicates growing investor confidence. However, the decline in promoter shareholding from 42.60% in December 2022 to the current figure raises questions about long-term commitment. The number of shareholders has also seen a significant rise, reaching 4,16,518 by March 2025, suggesting increasing retail interest in the company. This evolving shareholding structure may reflect shifting market sentiments and highlights the importance of maintaining investor trust through consistent performance and transparency in operations.
Outlook, Risks, and Final Insight
Looking ahead, Vakrangee faces both opportunities and challenges. The company must leverage its operational efficiencies to enhance profitability, especially given its low ROE and ROCE figures, which are critical for attracting further investment. Risks include the volatility in revenue streams, evidenced by the fluctuating sales figures over the past quarters, which could impact future financial stability. Additionally, the high P/BV ratio may deter potential investors if the company fails to demonstrate growth. On the other hand, the strong liquidity position and low debt levels provide a buffer against economic uncertainties. Continuous improvement in operational metrics and clarity in strategic direction will be vital for Vakrangee to regain its footing in the competitive IT consulting market and drive sustainable growth. The company’s ability to adapt to market demands and enhance shareholder value will ultimately determine its future trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 56.2 Cr. | 17.8 | 17.8/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 149 Cr. | 138 | 194/99.8 | 22.8 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 35.5 Cr. | 277 | 310/140 | 25.3 | 26.7 | 0.36 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 5.50 Cr. | 1.02 | 1.73/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 20,043.17 Cr | 544.64 | 86.66 | 123.78 | 0.55% | 14.88% | 20.92% | 6.84 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 234.07 | 49.15 | 50.94 | 55.59 | 51.54 | 51.56 | 53.89 | 58.70 | 65.25 | 67.88 | 63.18 | 68.84 | 69.08 |
| Expenses | 224.43 | 44.15 | 46.22 | 48.97 | 45.62 | 45.33 | 46.28 | 52.14 | 60.01 | 62.40 | 56.35 | 61.02 | 61.81 |
| Operating Profit | 9.64 | 5.00 | 4.72 | 6.62 | 5.92 | 6.23 | 7.61 | 6.56 | 5.24 | 5.48 | 6.83 | 7.82 | 7.27 |
| OPM % | 4.12% | 10.17% | 9.27% | 11.91% | 11.49% | 12.08% | 14.12% | 11.18% | 8.03% | 8.07% | 10.81% | 11.36% | 10.52% |
| Other Income | 1.36 | -0.05 | 0.86 | 0.31 | 0.87 | 1.32 | 0.39 | 0.89 | 0.82 | 0.75 | 1.55 | 1.51 | 1.64 |
| Interest | 0.00 | 0.00 | 1.52 | 1.99 | 1.83 | 1.93 | 1.96 | 0.45 | 0.60 | 0.38 | 0.40 | 0.36 | 0.35 |
| Depreciation | 4.19 | 4.01 | 3.39 | 3.95 | 3.97 | 3.92 | 3.85 | 3.89 | 4.28 | 4.24 | 4.29 | 4.30 | 4.45 |
| Profit before tax | 6.81 | 0.94 | 0.67 | 0.99 | 0.99 | 1.70 | 2.19 | 3.11 | 1.18 | 1.61 | 3.69 | 4.67 | 4.11 |
| Tax % | 29.22% | 86.17% | -1.49% | 49.49% | 57.58% | 26.47% | 0.00% | 27.97% | 50.85% | 35.40% | 31.71% | 28.91% | 26.28% |
| Net Profit | 4.82 | 0.13 | 0.68 | 0.49 | 0.42 | 1.24 | 2.19 | 2.24 | 0.59 | 1.04 | 2.52 | 3.32 | 3.03 |
| EPS in Rs | 0.05 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 |
Last Updated: December 28, 2025, 3:31 pm
Below is a detailed analysis of the quarterly data for Vakrangee Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 69.08 Cr.. The value appears strong and on an upward trend. It has increased from 68.84 Cr. (Jun 2025) to 69.08 Cr., marking an increase of 0.24 Cr..
- For Expenses, as of Sep 2025, the value is 61.81 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 61.02 Cr. (Jun 2025) to 61.81 Cr., marking an increase of 0.79 Cr..
- For Operating Profit, as of Sep 2025, the value is 7.27 Cr.. The value appears to be declining and may need further review. It has decreased from 7.82 Cr. (Jun 2025) to 7.27 Cr., marking a decrease of 0.55 Cr..
- For OPM %, as of Sep 2025, the value is 10.52%. The value appears to be declining and may need further review. It has decreased from 11.36% (Jun 2025) to 10.52%, marking a decrease of 0.84%.
- For Other Income, as of Sep 2025, the value is 1.64 Cr.. The value appears strong and on an upward trend. It has increased from 1.51 Cr. (Jun 2025) to 1.64 Cr., marking an increase of 0.13 Cr..
- For Interest, as of Sep 2025, the value is 0.35 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.36 Cr. (Jun 2025) to 0.35 Cr., marking a decrease of 0.01 Cr..
- For Depreciation, as of Sep 2025, the value is 4.45 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.30 Cr. (Jun 2025) to 4.45 Cr., marking an increase of 0.15 Cr..
- For Profit before tax, as of Sep 2025, the value is 4.11 Cr.. The value appears to be declining and may need further review. It has decreased from 4.67 Cr. (Jun 2025) to 4.11 Cr., marking a decrease of 0.56 Cr..
- For Tax %, as of Sep 2025, the value is 26.28%. The value appears to be improving (decreasing) as expected. It has decreased from 28.91% (Jun 2025) to 26.28%, marking a decrease of 2.63%.
- For Net Profit, as of Sep 2025, the value is 3.03 Cr.. The value appears to be declining and may need further review. It has decreased from 3.32 Cr. (Jun 2025) to 3.03 Cr., marking a decrease of 0.29 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.03. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:26 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,952 | 2,780 | 3,191 | 4,000 | 6,502 | 1,508 | 685 | 314 | 194 | 197 | 213 | 255 | 269 |
| Expenses | 1,417 | 2,057 | 2,370 | 3,054 | 5,495 | 1,530 | 661 | 286 | 176 | 179 | 186 | 231 | 242 |
| Operating Profit | 535 | 723 | 821 | 946 | 1,007 | -22 | 24 | 28 | 18 | 19 | 26 | 24 | 27 |
| OPM % | 27% | 26% | 26% | 24% | 15% | -1% | 3% | 9% | 9% | 9% | 12% | 9% | 10% |
| Other Income | 6 | 6 | 6 | 5 | 34 | 82 | 83 | 70 | 2 | 1 | 3 | 4 | 5 |
| Interest | 78 | 75 | 56 | 50 | 10 | 0 | 0 | 0 | 0 | 2 | 8 | 2 | 1 |
| Depreciation | 181 | 165 | 164 | 73 | 7 | 9 | 15 | 15 | 15 | 16 | 16 | 17 | 17 |
| Profit before tax | 282 | 489 | 606 | 828 | 1,024 | 51 | 92 | 83 | 5 | 3 | 6 | 10 | 14 |
| Tax % | 38% | 34% | 35% | 36% | 34% | 51% | 22% | 24% | 100% | 63% | 26% | 33% | |
| Net Profit | 175 | 322 | 395 | 531 | 680 | 25 | 71 | 63 | 0 | 1 | 4 | 6 | 10 |
| EPS in Rs | 1.74 | 3.20 | 3.73 | 5.02 | 6.43 | 0.24 | 0.67 | 0.59 | 0.00 | 0.01 | 0.04 | 0.06 | 0.09 |
| Dividend Payout % | 7% | 4% | 17% | 20% | 4% | 105% | 37% | 17% | 530% | 122% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 84.00% | 22.67% | 34.43% | 28.06% | -96.32% | 184.00% | -11.27% | -100.00% | 300.00% | 50.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -61.33% | 11.76% | -6.37% | -124.38% | 280.32% | -195.27% | -88.73% | 400.00% | -250.00% |
Vakrangee Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -21% |
| 5 Years: | -18% |
| 3 Years: | 10% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -32% |
| 5 Years: | -37% |
| 3 Years: | % |
| TTM: | 31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -16% |
| 5 Years: | -19% |
| 3 Years: | -34% |
| 1 Year: | -58% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| Last Year: | 4% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 4, 2025, 2:11 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 50 | 50 | 53 | 53 | 106 | 106 | 106 | 106 | 106 | 106 | 106 | 108 | 108 |
| Reserves | 729 | 1,157 | 1,530 | 2,001 | 2,487 | 2,496 | 2,531 | 2,558 | 22 | 18 | 56 | 94 | 100 |
| Borrowings | 492 | 416 | 320 | 144 | 0 | 0 | 0 | 0 | 27 | 58 | 12 | 5 | 4 |
| Other Liabilities | 453 | 414 | 189 | 71 | 400 | 116 | 182 | 212 | 178 | 116 | 126 | 102 | 130 |
| Total Liabilities | 1,725 | 2,037 | 2,092 | 2,268 | 2,993 | 2,718 | 2,819 | 2,876 | 333 | 298 | 300 | 309 | 343 |
| Fixed Assets | 436 | 273 | 132 | 29 | 90 | 143 | 149 | 156 | 139 | 127 | 114 | 110 | 119 |
| CWIP | 48 | 10 | 0 | 0 | 3 | 13 | 5 | 5 | 6 | 8 | 10 | 17 | 9 |
| Investments | 3 | 2 | 2 | 2 | 29 | 4 | 3 | 1 | 2 | 3 | 7 | 4 | 5 |
| Other Assets | 1,238 | 1,753 | 1,959 | 2,238 | 2,871 | 2,558 | 2,662 | 2,714 | 186 | 160 | 169 | 177 | 210 |
| Total Assets | 1,725 | 2,037 | 2,092 | 2,268 | 2,993 | 2,718 | 2,819 | 2,876 | 333 | 298 | 300 | 309 | 343 |
Below is a detailed analysis of the balance sheet data for Vakrangee Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 108.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 108.00 Cr..
- For Reserves, as of Sep 2025, the value is 100.00 Cr.. The value appears strong and on an upward trend. It has increased from 94.00 Cr. (Mar 2025) to 100.00 Cr., marking an increase of 6.00 Cr..
- For Borrowings, as of Sep 2025, the value is 4.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 5.00 Cr. (Mar 2025) to 4.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 130.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 102.00 Cr. (Mar 2025) to 130.00 Cr., marking an increase of 28.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 343.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 309.00 Cr. (Mar 2025) to 343.00 Cr., marking an increase of 34.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 119.00 Cr.. The value appears strong and on an upward trend. It has increased from 110.00 Cr. (Mar 2025) to 119.00 Cr., marking an increase of 9.00 Cr..
- For CWIP, as of Sep 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 17.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 8.00 Cr..
- For Investments, as of Sep 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 210.00 Cr.. The value appears strong and on an upward trend. It has increased from 177.00 Cr. (Mar 2025) to 210.00 Cr., marking an increase of 33.00 Cr..
- For Total Assets, as of Sep 2025, the value is 343.00 Cr.. The value appears strong and on an upward trend. It has increased from 309.00 Cr. (Mar 2025) to 343.00 Cr., marking an increase of 34.00 Cr..
Notably, the Reserves (100.00 Cr.) exceed the Borrowings (4.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 43.00 | 307.00 | 501.00 | 802.00 | 1.00 | -22.00 | 24.00 | 28.00 | -9.00 | -39.00 | 14.00 | 19.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 144 | 157 | 97 | 75 | 73 | 319 | 729 | 1,301 | 79 | 74 | 75 | 39 |
| Inventory Days | 45 | 31 | 81 | 223 | ||||||||
| Days Payable | 71 | 39 | 18 | 217 | ||||||||
| Cash Conversion Cycle | 119 | 149 | 160 | 75 | 73 | 319 | 729 | 1,301 | 79 | 74 | 75 | 45 |
| Working Capital Days | 66 | 124 | 137 | 129 | 55 | 310 | 894 | 2,188 | -145 | -53 | -6 | 4 |
| ROCE % | 31% | 39% | 37% | 43% | 43% | 2% | 3% | 3% | 0% | 3% | 7% | 6% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 0.06 | 0.04 | 0.01 | 1.03 | 0.59 |
| Diluted EPS (Rs.) | 0.06 | 0.04 | 0.01 | 1.03 | 0.59 |
| Cash EPS (Rs.) | 0.21 | 0.18 | 0.15 | 1.18 | 0.73 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.64 | 1.14 | 1.17 | 25.93 | 25.15 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.64 | 1.14 | 1.17 | 25.93 | 25.15 |
| Revenue From Operations / Share (Rs.) | 2.35 | 2.01 | 1.86 | 7.35 | 2.97 |
| PBDIT / Share (Rs.) | 0.25 | 0.27 | 0.18 | 1.50 | 0.92 |
| PBIT / Share (Rs.) | 0.10 | 0.12 | 0.03 | 1.35 | 0.78 |
| PBT / Share (Rs.) | 0.08 | 0.05 | 0.02 | 1.34 | 0.78 |
| Net Profit / Share (Rs.) | 0.05 | 0.04 | 0.01 | 1.03 | 0.59 |
| NP After MI And SOA / Share (Rs.) | 0.06 | 0.04 | 0.01 | 1.03 | 0.59 |
| PBDIT Margin (%) | 11.02 | 13.51 | 9.98 | 20.37 | 31.06 |
| PBIT Margin (%) | 4.48 | 6.12 | 2.12 | 18.39 | 26.35 |
| PBT Margin (%) | 3.76 | 2.75 | 1.35 | 18.17 | 26.35 |
| Net Profit Margin (%) | 2.50 | 2.04 | 0.50 | 14.06 | 19.97 |
| NP After MI And SOA Margin (%) | 2.61 | 2.04 | 0.50 | 14.06 | 19.97 |
| Return on Networth / Equity (%) | 3.75 | 3.61 | 0.81 | 3.98 | 2.35 |
| Return on Capital Employeed (%) | 4.85 | 6.92 | 2.68 | 5.20 | 3.10 |
| Return On Assets (%) | 2.15 | 1.45 | 0.33 | 3.73 | 2.18 |
| Long Term Debt / Equity (X) | 0.00 | 0.06 | 0.10 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.00 | 0.10 | 0.46 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.83 | 0.71 | 0.10 | 0.24 | 0.08 |
| Current Ratio (X) | 2.15 | 1.40 | 1.05 | 11.93 | 10.20 |
| Quick Ratio (X) | 1.90 | 1.40 | 1.04 | 11.90 | 10.17 |
| Inventory Turnover Ratio (X) | 26.84 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 81.17 | 121.71 | 527.21 | 9.67 | 42.17 |
| Dividend Payout Ratio (CP) (%) | 23.13 | 26.43 | 32.07 | 8.47 | 34.13 |
| Earning Retention Ratio (%) | 18.83 | -21.71 | -427.21 | 90.33 | 57.83 |
| Cash Earning Retention Ratio (%) | 76.87 | 73.57 | 67.93 | 91.53 | 65.87 |
| Interest Coverage Ratio (X) | 15.39 | 3.72 | 13.01 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | 4.50 | 1.49 | 1.66 | 0.00 | 0.00 |
| Enterprise Value (Cr.) | 947.72 | 2066.51 | 1718.30 | 3625.04 | 5916.69 |
| EV / Net Operating Revenue (X) | 3.72 | 9.72 | 8.71 | 4.66 | 18.83 |
| EV / EBITDA (X) | 33.70 | 71.95 | 87.18 | 22.84 | 60.61 |
| MarketCap / Net Operating Revenue (X) | 4.00 | 9.89 | 8.60 | 4.73 | 18.89 |
| Retention Ratios (%) | 18.82 | -21.71 | -427.21 | 90.32 | 57.82 |
| Price / BV (X) | 5.75 | 17.47 | 13.70 | 1.34 | 2.23 |
| Price / Net Operating Revenue (X) | 4.00 | 9.89 | 8.60 | 4.73 | 18.89 |
| EarningsYield | 0.01 | 0.00 | 0.00 | 0.02 | 0.01 |
After reviewing the key financial ratios for Vakrangee Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.06, marking an increase of 0.02.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.06, marking an increase of 0.02.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 3. It has increased from 0.18 (Mar 24) to 0.21, marking an increase of 0.03.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.64. It has increased from 1.14 (Mar 24) to 1.64, marking an increase of 0.50.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.64. It has increased from 1.14 (Mar 24) to 1.64, marking an increase of 0.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2.35. It has increased from 2.01 (Mar 24) to 2.35, marking an increase of 0.34.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 2. It has decreased from 0.27 (Mar 24) to 0.25, marking a decrease of 0.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.10. This value is within the healthy range. It has decreased from 0.12 (Mar 24) to 0.10, marking a decrease of 0.02.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.08. This value is within the healthy range. It has increased from 0.05 (Mar 24) to 0.08, marking an increase of 0.03.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 2. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 2. It has increased from 0.04 (Mar 24) to 0.06, marking an increase of 0.02.
- For PBDIT Margin (%), as of Mar 25, the value is 11.02. This value is within the healthy range. It has decreased from 13.51 (Mar 24) to 11.02, marking a decrease of 2.49.
- For PBIT Margin (%), as of Mar 25, the value is 4.48. This value is below the healthy minimum of 10. It has decreased from 6.12 (Mar 24) to 4.48, marking a decrease of 1.64.
- For PBT Margin (%), as of Mar 25, the value is 3.76. This value is below the healthy minimum of 10. It has increased from 2.75 (Mar 24) to 3.76, marking an increase of 1.01.
- For Net Profit Margin (%), as of Mar 25, the value is 2.50. This value is below the healthy minimum of 5. It has increased from 2.04 (Mar 24) to 2.50, marking an increase of 0.46.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.61. This value is below the healthy minimum of 8. It has increased from 2.04 (Mar 24) to 2.61, marking an increase of 0.57.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.75. This value is below the healthy minimum of 15. It has increased from 3.61 (Mar 24) to 3.75, marking an increase of 0.14.
- For Return on Capital Employeed (%), as of Mar 25, the value is 4.85. This value is below the healthy minimum of 10. It has decreased from 6.92 (Mar 24) to 4.85, marking a decrease of 2.07.
- For Return On Assets (%), as of Mar 25, the value is 2.15. This value is below the healthy minimum of 5. It has increased from 1.45 (Mar 24) to 2.15, marking an increase of 0.70.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.00, marking a decrease of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.10 (Mar 24) to 0.00, marking a decrease of 0.10.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.83. It has increased from 0.71 (Mar 24) to 0.83, marking an increase of 0.12.
- For Current Ratio (X), as of Mar 25, the value is 2.15. This value is within the healthy range. It has increased from 1.40 (Mar 24) to 2.15, marking an increase of 0.75.
- For Quick Ratio (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has increased from 1.40 (Mar 24) to 1.90, marking an increase of 0.50.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 26.84. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 26.84, marking an increase of 26.84.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 81.17. This value exceeds the healthy maximum of 50. It has decreased from 121.71 (Mar 24) to 81.17, marking a decrease of 40.54.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 23.13. This value is within the healthy range. It has decreased from 26.43 (Mar 24) to 23.13, marking a decrease of 3.30.
- For Earning Retention Ratio (%), as of Mar 25, the value is 18.83. This value is below the healthy minimum of 40. It has increased from -21.71 (Mar 24) to 18.83, marking an increase of 40.54.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 76.87. This value exceeds the healthy maximum of 70. It has increased from 73.57 (Mar 24) to 76.87, marking an increase of 3.30.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 15.39. This value is within the healthy range. It has increased from 3.72 (Mar 24) to 15.39, marking an increase of 11.67.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.50. This value is within the healthy range. It has increased from 1.49 (Mar 24) to 4.50, marking an increase of 3.01.
- For Enterprise Value (Cr.), as of Mar 25, the value is 947.72. It has decreased from 2,066.51 (Mar 24) to 947.72, marking a decrease of 1,118.79.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.72. This value exceeds the healthy maximum of 3. It has decreased from 9.72 (Mar 24) to 3.72, marking a decrease of 6.00.
- For EV / EBITDA (X), as of Mar 25, the value is 33.70. This value exceeds the healthy maximum of 15. It has decreased from 71.95 (Mar 24) to 33.70, marking a decrease of 38.25.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.00. This value exceeds the healthy maximum of 3. It has decreased from 9.89 (Mar 24) to 4.00, marking a decrease of 5.89.
- For Retention Ratios (%), as of Mar 25, the value is 18.82. This value is below the healthy minimum of 30. It has increased from -21.71 (Mar 24) to 18.82, marking an increase of 40.53.
- For Price / BV (X), as of Mar 25, the value is 5.75. This value exceeds the healthy maximum of 3. It has decreased from 17.47 (Mar 24) to 5.75, marking a decrease of 11.72.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.00. This value exceeds the healthy maximum of 3. It has decreased from 9.89 (Mar 24) to 4.00, marking a decrease of 5.89.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vakrangee Ltd:
- Net Profit Margin: 2.5%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.85% (Industry Average ROCE: 14.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.75% (Industry Average ROE: 20.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.5
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.9
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 86.1 (Industry average Stock P/E: 86.66)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.5%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | Vakrangee Corporate House, Plot No 93, Road No. 16, Mumbai Maharashtra 400093 | info@vakrangee.in http://www.vakrangee.in |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Divya Nandwana | Executive Chairperson |
| Mr. Vedant Nandwana | Managing Director |
| Mr. Hari Chand Mittal | Ind. Non-Executive Director |
| Ms. Savita Keni | Independent Director |
| Mr. L K Shamsunder | Non Exe.Non Ind. & Nominee Director |
| Mr. Sandeep Gaware | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Vakrangee Ltd?
Vakrangee Ltd's intrinsic value (as of 30 December 2025) is 4.95 which is 35.96% lower the current market price of 7.73, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 834 Cr. market cap, FY2025-2026 high/low of 38.2/7.60, reserves of ₹100 Cr, and liabilities of 343 Cr.
What is the Market Cap of Vakrangee Ltd?
The Market Cap of Vakrangee Ltd is 834 Cr..
What is the current Stock Price of Vakrangee Ltd as on 30 December 2025?
The current stock price of Vakrangee Ltd as on 30 December 2025 is 7.73.
What is the High / Low of Vakrangee Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vakrangee Ltd stocks is 38.2/7.60.
What is the Stock P/E of Vakrangee Ltd?
The Stock P/E of Vakrangee Ltd is 86.1.
What is the Book Value of Vakrangee Ltd?
The Book Value of Vakrangee Ltd is 1.93.
What is the Dividend Yield of Vakrangee Ltd?
The Dividend Yield of Vakrangee Ltd is 0.00 %.
What is the ROCE of Vakrangee Ltd?
The ROCE of Vakrangee Ltd is 5.86 %.
What is the ROE of Vakrangee Ltd?
The ROE of Vakrangee Ltd is 3.65 %.
What is the Face Value of Vakrangee Ltd?
The Face Value of Vakrangee Ltd is 1.00.